Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study

BACKGROUND: COPD-related deaths are increasing in Japan, with ~5.3 million people at risk. METHODS: The SHINE was a 26-week, multicenter, randomized, double-blind, parallel-group study that evaluated safety and efficacy of indacaterol (IND)/glycopyrronium (GLY) 110/50 μg once daily (od) compared wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Shu, Ikeuchi, Hisataro, Murata, Shujiro, Kitawaki, Tetsuji, Ikeda, Kimitoshi, Banerji, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066848/
https://www.ncbi.nlm.nih.gov/pubmed/27785010
http://dx.doi.org/10.2147/COPD.S111408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066848/
https://www.ncbi.nlm.nih.gov/pubmed/27785010
http://dx.doi.org/10.2147/COPD.S111408

Ejemplares similares